Morning Breakouts

Latest KFF Health News Stories

There’s Been Few Breakthroughs In Alzheimer’s Drugs In Decades. Where’s The Demand For Progress?

Morning Briefing

In other diseases, loud and outraged patient advocates have played a crucial role in getting experimental treatments and drugs to trial. When it comes to Alzheimer’s, though, experts say there isn’t that energy to push for a cure. In other public health news: cancer and elephants, brain injuries, female doctors, race, Ebola and tainted blood pressure meds.

Some Of Country’s Most Trusted Health Websites Have Outdated, Misleading Information For Pregnant Women

Morning Briefing

From the sites of one of the top-ranked hospitals in the country to Harvard University, ProPublica finds errors and misleading information about preeclampsia, an extremely dangerous condition for pregnant women. ProPublica’s “Lost Mothers” series looks at why the country has such a high maternal mortality rate. In other news on women’s health: pregnancy prevention apps and abortion clinics.

New York Sues Purdue Pharma, Accuses Opioid Maker Of Widespread Fraud

Morning Briefing

New York joins dozens of other states suing the manufacturer of OxyContin. “The opioid epidemic was manufactured by unscrupulous distributors who developed a $400 billion industry pumping human misery into our communities,” Gov. Andrew Cuomo (D-N.Y.) said.

First-In-The-Nation Plan Would Taper Oregon’s Chronic Pain Patients’ Opioid Prescriptions Down To Zero

Morning Briefing

Officials say it’s reducing the patients’ exposure to harmful overprescribing practices, but critics warn that it will cause people to seek out opioids by any means necessary. In other news on the epidemic: the dangers of overdose for postpartum women who have been addicted to opioids; a look at grieving families on the frontlines of the crisis; how the issue could be a winning topic for Democrats; and more.

With Cost-Effectiveness Threshold, CVS Wants To Harness Power Of The Market To Drive Down Drug Prices

Morning Briefing

In the midst of criticism that pharmacy benefits managers are not doing enough to drive down costs, CVS has announced that it will let its clients exclude from their formularies any new drugs that exceed the threshold of $100,000 per quality-of-life years.

‘Delay, Deny And Hope You Die’: NFL’s Byzantine Rules Stymie Ex-Players Seeking Health Benefits

Morning Briefing

But Paul Scott, who worked as the NFL’s benefit plan point person, wants to change that. He’s hoping to help former players through the application process to get the disability benefits they’ve earned. Meanwhile, experts find fault in the way the University of Maryland treated football player Jordan McNair when he suffered from heatstroke, which led to his death.

Concentrated, Intensive Programs Offer Short-Term Alternative To Traditional Weekly Therapy Sessions

Morning Briefing

Some patients can finish therapy in just a few weeks. The model is gaining popularity because it is proving to be as effective as long-term weekly treatments. In other public health news: vaping, med students, Lyme disease, autism, HPV, toxins in water, work wellness programs and more.

New Algorithm Lets Scientists Better Calculate Person’s Chances Of Getting Five Serious Health Conditions

Morning Briefing

The researchers are now building a website that will allow anyone to upload genetic data. Users will receive risk scores for heart disease, breast cancer, Type 2 diabetes, chronic inflammatory bowel disease and atrial fibrillation. But scientists emphasize that DNA is not destiny, and that the results don’t account for a healthy diet and exercise.

U.S. To Dole Out $1.8 Million Grant To Teach Students Bleeding-Control Techniques In Case Of Mass Shooting

Morning Briefing

“Similar to how students learn health education and driver’s education, they must learn proper bleeding control techniques using commonly available materials,” according to the Department of Homeland Security notice, “including how to use their hands, dressings and tourniquets.”

Mayo Clinic Nabs Top Spot In National Hospital Ranking Beating Out Cleveland Clinic

Morning Briefing

The U.S. News & World Report analyzed 4,500 hospitals based on several factors, including performance in 16 specialty areas and reputation. This year, the report put a greater emphasis on patient outcomes.

Activist Investor Icahn Drops Opposition To Cigna-Express Scripts Deal After Advisory Firms Signal Their Support

Morning Briefing

Billionaire Carl Icahn had called the deal a “$60 billion folly,” but is now walking back his opposition in light of recommendations from Institutional Shareholder Services and Glass Lewis. The latter called the insurer’s offer for the pharmacy benefits manager “both strategically and financially compelling, structured in a reasonable manner from a valuation standpoint for Cigna shareholders.”